US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cryo-Cell International, Inc. - Common Stock
(NY:
CCEL
)
4.360
+0.190 (+4.56%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cryo-Cell International, Inc. - Common Stock
Cryo-Cell Intl (NYSEARCA:CCEL) Q3 Profit Surges Past Estimates on Flat Revenue
↗
October 09, 2026
Via
Chartmill
Cryo-Cell International (NYSEARCA:CCEL) Shares Dip on Mixed Quarter Despite Earnings Beat
↗
July 15, 2026
Via
Chartmill
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024
↗
July 15, 2024
CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 26, 2024
Via
Benzinga
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024
↗
April 15, 2024
CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 26, 2023
Via
Benzinga
Looking Into Cryo-Cell International's Return On Capital Employed
↗
April 24, 2023
Via
Benzinga
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
↗
October 05, 2022
Losers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 04, 2022
Gainers
Via
Benzinga
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
↗
September 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
Via
Benzinga
